<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD011423-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD011423-sec-0015"></div> <div class="table" id="CD011423-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">APC + OFD compared to OFD (9‐12 months follow‐up) for treating periodontal infrabony defects</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="table-header separated">
<td align="" valign="" colspan="7" rowspan="1" class="table-header"> <p><b>APC + OFD compared to OFD (9‐12 months follow‐up) for treating periodontal infrabony defects</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients affected by infrabony defects requiring surgical treatment<br><b>Settings:</b> tertiary care<br><b>Intervention:</b> APC + OFD<br><b>Comparison:</b> OFD </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Number of participants/defects<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>OFD </b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>APC + OFD</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Change in probing depth (PD) (mm)</b> </p> <p><b>(9‐12 months follow‐up)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>Mean PD change (gain) across control groups ranged from 2.40 to 3.68 (2.36) mm</p> <p>Mean PD baseline value was 7.92 mm (95% CI 6.25 to 9.54)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean PD change (gain) in the intervention groups was <b>1.29 mm higher</b> (1.00 to 1.58 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean difference 1.29 (1.00 to 1.58) mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>510<br> (12 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>very low</b><sup>1, 2</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There is evidence of an advantage in using APC</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Change in clinical attachment level (CAL) (mm)</b> </p> <p><b>(9‐12 months follow‐up)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>Mean CAL change (gain) across control groups ranged from 1.27 to 4.14 (2.03) mm</p> <p>Mean CAL baseline value was 6.78 mm (95% CI 5.56 to 7.54)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean CAL change (gain) in the intervention groups was <b>1.47 mm higher</b> (1.11 to 1.82 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean difference 1.47 (1.11 to 1.82) mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>510<br> (12 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>very low</b><sup>1, 2</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There is evidence of an advantage in using APC</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Change in radiographic bone defect filling (RBF) (%)</b> </p> <p><b>(9‐12 months follow‐up)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>Mean RBF change (gain) across control groups ranged from ‐3.60% to 54.20% (16.90%)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean RBF change (gain) in the intervention groups was <b>34.26% higher</b> (30.07 to 38.46 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean difference 34.26% (30.07 to 38.46)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>401<br> (9 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>very low</b><sup>1, 2</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There is evidence of an advantage in using APC</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup>The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><b>APC:</b> autologous platelet concentrates; <b>CAL:</b> clinical attachment level; <b>CI:</b> confidence interval; <b>OFD:</b> open flap debridement; <b>PD:</b> probing depth; <b>RBF:</b> radiographic bone defect filling. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by 2 levels for high risk of performance bias.<br><sup>2</sup>Downgraded by 2 levels for high heterogeneity. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD011423-tbl-0002"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 2.</span> <span class="table-title">APC + OFD + BG compared to OFD + BG (all follow‐ups) for treating periodontal infrabony defects</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="table-header separated">
<td align="" valign="" colspan="7" rowspan="1" class="table-header"> <p><b>APC + OFD + BG compared to OFD + BG (all follow‐ups) for treating periodontal infrabony defects</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients affected by infrabony defects requiring surgical treatment<br><b>Settings:</b> tertiary care<br><b>Intervention:</b> APC + OFD + BG<br><b>Comparison:</b> OFD + BG </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Number of participants/defects<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>OFD + BG </b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>APC + OFD + BG</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Change in probing depth (PD) (mm)</b> </p> <p><b>(All follow‐ups)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>Mean PD change (gain) across control groups ranged from 1.90 to 5.30 (3.54) mm</p> <p>Mean PD baseline value was 7.32 mm (95% CI 5.94 to 8.65)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean PD change (gain) in the intervention groups was <b>0.54 mm higher</b> (0.33 to 0.75 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean difference 0.54 (0.33 to 0.75) mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>569<br> (17 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>very low</b><sup>1, 2</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There is evidence of an advantage in using APC</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Change in clinical attachment level (CAL) (mm)</b> </p> <p><b>(All follow‐ups)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>Mean CAL change (gain) across control groups ranged from 1.30 to 4.70 (3.20) mm</p> <p>Mean CAL baseline value was 7.34 mm (95% CI 5.21 to 9.82)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean CAL change (gain) in the intervention groups was <b>0.72 mm higher</b> (0.43 to 1.00 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean difference 0.72 (0.43 to 1.00) mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>569<br> (17 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>very low</b><sup>1, 2</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There is evidence of an advantage in using APC</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Change in radiographic bone defect filling (RBF) (%)</b> </p> <p><b>(All follow‐ups)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>Mean RBF change (gain) across control groups ranged from 9.20% to 57.20% (40.54%)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean RBF change (gain) in the intervention groups was <b>8.10% higher</b> (5.26 to 10.94 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean difference 8.10% (5.26 to 10.94)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>420<br> (11 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>very low</b><sup>1, 2</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There is evidence of an advantage in using APC</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup>The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><b>APC:</b> autologous platelet concentrates; <b>BG:</b> bone graft; <b>CAL:</b> clinical attachment level; <b>CI:</b> confidence interval; <b>OFD:</b> open flap debridement; <b>PD:</b> probing depth; <b>RBF:</b> radiographic bone defect filling. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by 2 levels for high risk of performance bias.<br><sup>2</sup>Downgraded by 2 levels for high heterogeneity. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD011423-tbl-0003"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 3.</span> <span class="table-title">APC + GTR compared to GTR (all follow‐ups) for treating periodontal infrabony defects</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="table-header separated">
<td align="" valign="" colspan="7" rowspan="1" class="table-header"> <p><b>APC + GTR compared to GTR (all follow‐ups) for treating periodontal infrabony defects</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients affected by infrabony defects requiring surgical treatment<br><b>Settings:</b> tertiary care<br><b>Intervention:</b> APC + GTR<br><b>Comparison:</b> GTR </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Number of participants/defects<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>GTR </b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>APC + GTR</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Change in probing depth (PD) (mm)</b> </p> <p><b>(All follow‐ups)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>Mean PD change (gain) across control groups ranged from 3.19 to 6.00 mm (4.40 mm)</p> <p>Mean PD baseline value was 8.67 mm (95% CI 6.29 to 10.31)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean PD change (gain) in the intervention groups was <b>0.92 mm higher</b> (‐0.02 lower to 1.86 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean difference 0.92 mm (‐0.02 to 1.86)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>248<br> (7 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>very low</b><sup>1, 2, 3</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There is insufficient evidence of an advantage in using APC</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Change in clinical attachment level (CAL) (mm)</b> </p> <p><b>(All follow‐ups)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>Mean CAL change (gain) across control groups ranged from 3.38 to 5.20 mm (4.38 mm)</p> <p>Mean CAL baseline value was 9.40 mm (95% CI 5.97 to 11.40)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean CAL change (gain) in the intervention groups was <b>0.42 mm higher</b> (‐0.02 lower to 0.86 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean difference 0.42 mm (‐0.02 to 0.86)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>248<br> (7 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>very low</b><sup>1, 2, 3</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There is insufficient evidence of an advantage in using APC</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup>The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><b>APC:</b> autologous platelet concentrates; <b>CAL:</b> clinical attachment level; <b>CI:</b> confidence interval; <b>GTR:</b> guided tissue regeneration; <b>OFD:</b> open flap debridement; <b>PD:</b> probing depth; <b>RBF:</b> radiographic bone defect filling. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by 2 levels for high risk of performance bias.<br><sup>2</sup>Downgraded by 2 levels for high heterogeneity.<br><sup>3</sup>Downgraded by 2 levels for imprecision (wide confidence interval and small sample size). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD011423-tbl-0004"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 4.</span> <span class="table-title">APC + EMD compared to EMD (all follow‐ups) for treating periodontal infrabony defects</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="table-header separated">
<td align="" valign="" colspan="7" rowspan="1" class="table-header"> <p><b>APC + EMD compared to EMD (all follow‐ups) for treating periodontal infrabony defects</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients affected by infrabony defects requiring surgical treatment<br><b>Settings:</b> tertiary care<br><b>Intervention:</b> APC + EMD<br><b>Comparison:</b> EMD </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Number of participants/defects<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>EMD</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>APC + EMD</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Change in probing depth (PD) (mm)</b> </p> <p><b>(All follow‐ups)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>Mean PD change (gain) across control groups ranged from 3.87 to 5.90 mm (4.89 mm)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean PD change (gain) in the intervention groups was <b>0.13 mm higher</b> (‐0.05 lower to 0.30 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean difference 0.13 mm (‐0.05 to 0.30)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>75<br> (2 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>very low</b><sup>1, 2</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There is insufficient evidence of an advantage in using APC</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Change in clinical attachment level (CAL) (mm)</b> </p> <p><b>(All follow‐ups)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>Mean CAL change (gain) across control groups ranged from 3.30 to 5.00 mm (4.15 mm)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean CAL change (gain) in the intervention groups was <b>0.10 mm higher</b> (‐0.13 lower to 0.32 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean difference 0.10 mm (‐0.13 to 0.32)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>75<br> (2 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>very low</b><sup>1, 2</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There is insufficient evidence of an advantage in using APC</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Change in radiographic bone defect filling (RBF) (%)</b> </p> <p><b>(All follow‐ups)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>Only 1 study reported RBF outcome with a mean change in control groups of 18.30%</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean RBF change (gain) in the intervention group was <b>0.60% lower</b> (‐6.21 lower to 5.01 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean difference ‐0.60 (‐6.21 to 5.01)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>49<br> (1 study) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>very low</b><sup>1, 2</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There is insufficient evidence of an advantage in using APC</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup>The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><b>APC:</b> autologous platelet concentrates; <b>CAL:</b> clinical attachment level; <b>CI:</b> confidence interval; <b>EMD:</b> enamel matrix derivative; <b>OFD:</b> open flap debridement; <b>PD:</b> probing depth; <b>RBF:</b> radiographic bone defect filling. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by 2 levels for high risk of performance bias.<br><sup>2</sup>Downgraded by 2 levels for imprecision (wide confidence interval and small sample size). </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
